Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aptevo Therapeutics Inc. (APVO) vs Biorestorative Therapies, Inc. (BRTX)

Aptevo Therapeutics Inc. and Biorestorative Therapies, Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. and Biorestorative Therapies, Inc. are of similar size ($3.5M and $3.4M). Biorestorative Therapies, Inc. has negative trailing earnings, so its P/E is not meaningful; Aptevo Therapeutics Inc. trades at 0.0×. Aptevo Therapeutics Inc. grew revenue faster over the last twelve months: 92.9% against −8.47%. Aptevo Therapeutics Inc. has the higher net margin (0.00% vs −3,089.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Aptevo Therapeutics Inc. leads on 8 and Biorestorative Therapies, Inc. on 8.

Valuation

Metric APVO BRTX Biotechnology median
P/E 0.00 n/m 7.88
P/S 0.17 6.32 11.47
P/B 0.37 0.75 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.09 0.74
EV/Sales 0.00 (3.60) 10.73
Earnings yield 86,377.14% (839.22%) (28.84%)
Free cash flow yield (1,127.28%) (579.97%) (23.03%)

Profitability

Metric APVO BRTX Biotechnology median
Gross margin 0.00% 92.09% 65.16%
Operating margin 0.00% (3,974.66%) 0.00%
Net margin 0.00% (3,089.30%) 0.00%
Free cash flow margin 0.00% (3,302.04%) 0.00%
Return on equity (446.89%) (241.50%) (57.72%)
Return on assets (186.29%) (147.75%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APVO BRTX Biotechnology median
Revenue growth (TTM) 92.94% (8.47%) 5.64%
EPS growth (last fiscal year) 99.72% (36.21%) —
Revenue growth, 5-year CAGR (26.64%) 36.11% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO BRTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 2.35 4.73
Net debt to EBITDA 0.83 0.19 0.96

Dividend

Metric APVO BRTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric APVO BRTX Biotechnology median
Market cap 3.43m 3.47m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack